These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11264121)

  • 1. Discontinuing anticytomegalovirus therapy in patients with cytomegalovirus retinitis and AIDS.
    Jabs DA
    Br J Ophthalmol; 2001 Apr; 85(4):381-2. PubMed ID: 11264121
    [No Abstract]   [Full Text] [Related]  

  • 2. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Margolis TP
    Surv Ophthalmol; 2000; 44(5):455. PubMed ID: 10809654
    [No Abstract]   [Full Text] [Related]  

  • 3. Suspension of anticytomegalovirus maintenance therapy following immune recovery due to highly active antiretroviral therapy.
    Curi AL; Muralha A; Muralha L; Pavesio C
    Br J Ophthalmol; 2001 Apr; 85(4):471-3. PubMed ID: 11264139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy.
    Jabs DA; Bolton SG; Dunn JP; Palestine AG
    Am J Ophthalmol; 1998 Dec; 126(6):817-22. PubMed ID: 9860006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Whitcup SM; Fortin E; Lindblad AS; Griffiths P; Metcalf JA; Robinson MR; Manischewitz J; Baird B; Perry C; Kidd IM; Vrabec T; Davey RT; Falloon J; Walker RE; Kovacs JA; Lane HC; Nussenblatt RB; Smith J; Masur H; Polis MA
    JAMA; 1999 Nov; 282(17):1633-7. PubMed ID: 10553789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune recovery uveitis.
    Kuppermann BD; Holland GN
    Am J Ophthalmol; 2000 Jul; 130(1):103-6. PubMed ID: 11004267
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy.
    Robinson MR; Reed G; Csaky KG; Polis MA; Whitcup SM
    Am J Ophthalmol; 2000 Jul; 130(1):49-56. PubMed ID: 11004259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Jabs DA; Van Natta ML; Kempen JH; Reed Pavan P; Lim JI; Murphy RL; Hubbard LD
    Am J Ophthalmol; 2002 Jan; 133(1):48-61. PubMed ID: 11755839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active cytomegalovirus retinitis after the start of antiretroviral therapy.
    Heiden D; Tun N; Smithuis FN; Keenan JD; Oldenburg CE; Holland GN; Drew WL
    Br J Ophthalmol; 2019 Feb; 103(2):157-160. PubMed ID: 30196272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year follow-up of a cohort of profoundly immunosuppressed patients discontinuing therapy for cytomegalovirus retinitis.
    Sklar PA; Agyemang AF; Monastra R; Kress DR; Metcalf JA; Robinson MR; Masur H; Polis MA
    AIDS; 2004 Feb; 18(3):567-9. PubMed ID: 15090813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune recovery uveitis.
    Dunn JP
    Hopkins HIV Rep; 2001 Nov; 13(6):9-10. PubMed ID: 11727417
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytomegalovirus retinitis in HIV-infected patients with and without highly active antiretroviral therapy.
    Doan S; Cochereau I; Guvenisik N; Diraison MC; Mousalatti H; Thanh HX
    Am J Ophthalmol; 1999 Aug; 128(2):250-1. PubMed ID: 10458193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Zegans M; Marsh B; Walton RC
    Int Ophthalmol Clin; 2000; 40(2):127-35. PubMed ID: 10791261
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis.
    Holbrook JT; Colvin R; van Natta ML; Thorne JE; Bardsley M; Jabs DA;
    Am J Ophthalmol; 2011 Oct; 152(4):628-637.e1. PubMed ID: 21742304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus retinitis with a CD4+T cell count of 147.
    Rajasekharan C
    BMJ Case Rep; 2012 May; 2012():. PubMed ID: 22669025
    [No Abstract]   [Full Text] [Related]  

  • 16. Exploring the benefits and limits of highly active antiretroviral therapy.
    D'Aquila R; Walker B
    JAMA; 1999 Nov; 282(17):1668-9. PubMed ID: 10553795
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Uthayakumar S; Birthistle K; Dalton R; Hay PE
    Lancet; 1997 Aug; 350(9077):588-9; author reply 590. PubMed ID: 9284793
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.
    Vrabec TR; Baldassano VF; Whitcup SM
    Ophthalmology; 1998 Jul; 105(7):1259-64. PubMed ID: 9663231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis.
    Walmsley SL; Raboud J; Angel JB; Mazzulli T; Shen S; Casciaro L; Young CD; Moussa G; Gough K; Rachlis A; Hopkins J
    HIV Clin Trials; 2006; 7(1):1-9. PubMed ID: 16632459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.